Nu Skin Enterprises (NUS) Current Deferred Revenue (2015 - 2025)

Nu Skin Enterprises has disclosed Current Deferred Revenue across 11 years of filings, most recently posting $12.7 million for Q4 2025.

• In Q4 2025, Current Deferred Revenue fell 18.81% year-over-year to $12.7 million; the TTM figure through Dec 2025 stood at $12.7 million (down 18.81% YoY), while the FY2025 annual figure was $12.7 million, down 18.81% from the prior year.
• Current Deferred Revenue came in at $12.7 million for Q4 2025 at Nu Skin Enterprises, down from $15.7 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $33.1 million in Q4 2021 to a low of $12.7 million in Q4 2025.
• Average Current Deferred Revenue over 5 years is $21.8 million, with a median of $20.3 million recorded in 2023.
• Year-over-year, Current Deferred Revenue decreased 5.46% in 2021 and dropped 24.82% in 2023.
• Over 5 years, Current Deferred Revenue stood at $33.1 million in 2021, then slipped by 18.37% to $27.1 million in 2022, then retreated by 24.82% to $20.3 million in 2023, then fell by 22.86% to $15.7 million in 2024, then dropped by 18.81% to $12.7 million in 2025.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $12.7 million in Q4 2025, $15.7 million in Q4 2024, and $20.3 million in Q4 2023.